Elevance Health Q1 EPS Beats, Raises Guidance

Elevance Health posted Q1 adjusted EPS of $12.58, beating the $10.84 consensus by $1.74.
Operating revenue rose 1.5% YoY to $49.5 billion, topping the $48.2 billion estimate.
A $935 million CMS‑related accrual was recorded, yet full‑year EPS guidance was lifted to at least $26.75.
Operating cash flow jumped to $4.3 billion and $1.5 billion was returned to shareholders via buybacks and dividends.